To Measure or Not to Measure: Direct Oral Anticoagulant Laboratory Assay Monitoring in Clinical Practice
The need for therapeutic drug monitoring of direct oral anticoagulants (DOACs) remains an area of clinical equipoise. Although routine monitoring may be unnecessary given predictable pharmacokinetics in most patients, there may be altered pharmacokinetics in those with end organ dysfunction, such as...
Main Authors: | Tania Ahuja, Veronica Raco, Sharonlin Bhardwaj, David Green |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2023-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2023/9511499 |
Similar Items
-
Challenges to Laboratory Monitoring of Direct Oral Anticoagulants
by: Jesse Qiao MD, et al.
Published: (2024-03-01) -
Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
by: Claire Dunois
Published: (2021-04-01) -
Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01) -
Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants
by: S. R. Gilyarevsky, et al.
Published: (2023-07-01) -
Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01)